Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. (Q39944566)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. |
scientific article |
Statements
Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial (English)
Evelien de Jong
Jos A van Oers
Albertus Beishuizen
Piet Vos
Wytze J Vermeijden
Lenneke E Haas
Bert G Loef
Tom Dormans
Gertrude C van Melsen
Yvette C Kluiters
Hans Kemperman
Maarten J van den Elsen
Jeroen A Schouten
Jörn O Streefkerk
Hans G Krabbe
Hans Kieft
Georg H Kluge
Veerle C van Dam
Joost van Pelt
Laura Bormans
Martine Bokelman Otten
Auke C Reidinga
Jos W Twisk
Ewoudt M W van de Garde
Anne Marie G A de Smet
Jozef Kesecioglu
Armand R Girbes
Maarten W Nijsten